Mounjaro is the brand name for tirzepatide, a prescription medicine licensed in the United Kingdom for the treatment of type 2 diabetes mellitus and, more recently, for chronic weight management in adults with obesity or overweight with weight-related comorbidities (under the brand name Zepbound)
Ozempic was FDA-approved in 2017 for the treatment of type 2 diabetes
Remember, the goal is to manage your blood sugar levels, support weight loss, and maintain heart health, all while minimizing any discomfort from side effects
Newer triple agonists Retatrutide , the investigational triple agonist targeting GLP-1, GIP, and glucagon receptors, showed higher overall GI event rates in Phase 2 trials at its highest doses
Below is a comparison highlighting their unique contributions: In weight loss regimens, B6 helps manage treatment side effects, while B12 ensures energy levels remain stable and metabolic processes function effectively